AstraZeneca (United States)

Industry / private company


Location: Wilmington, United States (USA) (US) US

ROR: https://ror.org/043cec594

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

SERENA-6 visual patient-reported outcomes and safety: camizestrant for emerging ESR1m advanced breast cancer during first-line endocrine-based therapy (2026) Brufsky A, Park YH, Bidard FC, Mayer EL, Janni W, Ma C, Cristofanilli M, et al. Journal article Switching to camizestrant at ESR1 mutation emergence before disease progression during first-line treatment of hormone receptor-positive advanced breast cancer (SERENA-6): extended analysis of a double-blind, placebo-controlled, randomised, phase 3 trial (2026) Turner NC, Mayer EL, Park YH, Janni W, Ma C, Cristofanilli M, Bianchini G, et al. Journal article Treatment Strategies in Incident and Recurrent Hyperkalemia: Insights from the TRACK Study (2026) Ferraro PM, Shivappa N, Bakhai A, Bover J, Butler J, Fried L, Schneider M, et al. Journal article